---
title: Biomarkers / Test Results
---

Bryan Johnson's current results showcase the effectiveness of the Blueprint Protocol. Here are some of the markers he's currently tracking and reporting on:

| Biomarker | Result | Age Equivalent | Reduction | Optimal Clinical Outcomes Range (OCOR) |
|-----------|--------|----------------|-----------|----------------------------------------|
| [ALT](/docs/Reference/Biomarkers/alt) | OPTIMAL | 18 |  | <15 |
| [BMI](/docs/Reference/Biomarkers/bmi) | OPTIMAL | 22.8 |  | <22.5 |
| [Fasting plasma glucose](/docs/Reference/Biomarkers/fasting_plasma_glucose) | OPTIMAL | 82 | 28 (max reduction) | <95 |
| [Body Fat](/docs/Reference/Biomarkers/body_fat) | OPTIMAL | 6.9% | 16 (max reduction) | <10% |
| [Cholesterol (total)](/docs/Reference/Biomarkers/cholesterol_total) | OPTIMAL | 158 |  | - |
| [DHEA](/docs/Reference/Biomarkers/dhea) | OPTIMAL | 149 | 25 (max reduction) | < age 50 |
| [Free Testosterone Index](/docs/Reference/Biomarkers/free_testosterone_index) | OPTIMAL | 0.39 | 41 | < age 50 |
| [GGT](/docs/Reference/Biomarkers/ggt) | OPTIMAL | 13 |  | <14 |
| [Glutathione](/docs/Reference/Biomarkers/glutathione) | OPTIMAL | 227 | 29 | < age 30 |
| [Grip Strength Dominant](/docs/Reference/Biomarkers/grip_strength_dominant) | OPTIMAL | 134 | 33 (max reduction) | < age 30 |
| [Grip Strength Non-dominant](/docs/Reference/Biomarkers/grip_strength_non_dominant) | OPTIMAL | 124 | 43 (max reduction) | < age 30 |
| [HbA1C](/docs/Reference/Biomarkers/hba1c) | OPTIMAL | 4.5 | 28 (max reduction) | 4.5-5.6 |
| [HDL](/docs/Reference/Biomarkers/hdl) | OPTIMAL | 73 |  | 50 - 60 |
| [hsCRP](/docs/Reference/Biomarkers/hscrp) | OPTIMAL | 0.46 | 10 (max reduction) | <0.55 |
| [IGF-1](/docs/Reference/Biomarkers/igf_1) | OPTIMAL | 125 |  | 75 - 150 |
| [LDL](/docs/Reference/Biomarkers/ldl) | OPTIMAL | 74 |  | < 100 |
| [NAD](/docs/Reference/Biomarkers/nad) | OPTIMAL | 52.6 | 16 (max reduction) | < age 30 |
| [PSA](/docs/Reference/Biomarkers/psa) | OPTIMAL | 0.68 | 22 (max reduction) | < age 30 |
| [RDW](/docs/Reference/Biomarkers/rdw) | OPTIMAL | 11.3 | 18 (max reduction) | < age 30 |
| [SHBG](/docs/Reference/Biomarkers/shbg) | OPTIMAL | 68 |  | - |
| [TSH](/docs/Reference/Biomarkers/tsh) | OPTIMAL | 1.94 |  | 1 - 2.1 |
| [Triglycerides](/docs/Reference/Biomarkers/triglycerides) | OPTIMAL | 55 |  | 27 - 89 |
| [Testosterone](/docs/Reference/Biomarkers/testosterone) | OPTIMAL | 769 | 33 (max reduction) | - |
| [VO2 max treadmill](/docs/Reference/Biomarkers/vo2_max_treadmill) | OPTIMAL | 53.6 | 18 (max reduction) | < age 30 |
| [WBC](/docs/Reference/Biomarkers/wbc) | OPTIMAL | 4.5 |  | 3.5 - 6 |
| [20th percentile telomeres PBMC](/docs/Reference/Biomarkers/20th_percentile_telomeres_pbmc) | OPTIMAL | 7 | 28 (max reduction) | < age 30 |
